The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...
The drug offers a non-addictive alternative to opioids, marking 'an important public health milestone in acute pain ...
The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.
It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and ...